![](/img/cover-not-exists.png)
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen
Vignani, F., Russo, L., Tucci, M., Motta, M., Vellani, G., Tampellini, M., Papotti, M., Dogliotti, L., Berruti, A.Volume:
20
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdp456
Date:
December, 2009
File:
PDF, 38 KB
english, 2009